Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll - Thermo Fisher Scientific ( NYSE:TMO )
Thermo Fisher slashed 2025 EPS guidance to $21.76-$22.84 vs. $23.25 consensus. U.S.-China tariffs expected to cut 2025 revenue by $400 million and operating income by $375 million. Markets are messy-but the right setups can still deliver triple-digit gains.
https://www.benzinga.com/general/health-care/25/04/44966173/thermo-fisher-beats-q1-estimates-lowers-full-year-forecast-as-tariffs-and-costs-take-a-toll